Loading organizations...
Loading organizations...
Immuno-oncology company using adoptive cell therapy.
Tactiva Therapeutics has raised $35.0M across 1 funding round.
Tactiva Therapeutics has raised $35.0M in total across 1 funding round.
Tactiva Therapeutics has raised $35.0M in total across 1 funding round.
Tactiva Therapeutics's investors include Panacea Healthcare Partners, Efung Capital, VI Ventures.
Tactiva Therapeutics has raised $35.0M across 1 funding round. Most recently, it raised $35.0M Series A in December 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 3, 2018 | $35.0M Series A | Panacea Healthcare Partners | Efung Capital, VI Ventures |